<DOC>
	<DOC>NCT00056446</DOC>
	<brief_summary>The purpose of this study is to compare treatment with oxaliplatin/5-FU/leucovorin plus vatalanib versus oxaliplatin/5-FU/leucovorin plus placebo in patients with colorectal cancer that has spread to other organs and whose disease has worsened after treatment with irinotecan.</brief_summary>
	<brief_title>Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Vatalanib</mesh_term>
	<criteria>Inclusion criteria Confirmed adenocarcinoma of the colon or rectum in patients with metastatic disease One prior chemotherapy regimen with irinotecan and 5FU Evidence of progressive disease within 6 months after last dose of irinotecan WHO Performance Status of 0, 1, or 2 Measurable tumors Adequate hematologic status, liver and kidney function Life expectancy greater than 12 weeks Written informed consent obtained Exclusion criteria History or presence of central nervous system disease Patients with a history of another primary cancer within 5 years Prior chemotherapy within 3 weeks before entry to study Major surgery within 4 weeks or minor surgery within 2 weeks before entry to study Investigational drugs within 4 weeks before entry to study Prior therapy with oxaliplatin Peripheral neuropathy with functional impairment Female patients who are pregnant or breast feeding Any severe or uncontrolled medical condition which could prevent participation in study Chronic kidney disease Acute or chronic liver disease Patients taking Coumadin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Colorectal Cancer</keyword>
	<keyword>Oxaliplatin</keyword>
	<keyword>VEGF inhibitor</keyword>
	<keyword>Vatalanib</keyword>
	<keyword>PTK787</keyword>
	<keyword>Colon Cancer</keyword>
	<keyword>Colorectal Carcinoma</keyword>
	<keyword>Rectal Cancer</keyword>
	<keyword>Colorectal Tumor</keyword>
</DOC>